Ionis Pharmaceuticals IONS Debt Maturity - 2027
Debt Maturity - 2027 at other companies
Other financials
Where this comes from
Reported directly by Ionis Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree.
The official record: Ionis Pharmaceuticals’s 10-K, filed February 26, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ionis Pharmaceuticals's debt maturity - 2027.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Ionis Pharmaceuticals's debt maturity - 2027?
- Ionis Pharmaceuticals (IONS) reported debt maturity - 2027 of $580.09M in Q4 2025.
- What does debt maturity - 2027 mean?
- The amount of debt principal due for repayment in 2027.
- How do you interpret debt maturity - 2027?
- Higher amounts indicate a significant cash outflow requirement in that year, potentially necessitating refinancing or cash accumulation.
- How does debt maturity - 2027 compare across companies?
- Standardized across all public companies with fixed-term debt instruments.